Participant information leaflet (PIL) development #2: with user feedback
Optimising the PIL through using user feedback probably makes little or no difference to recruitment.
0%
The absolute increase is 0% (95% CI = 0% to 1%)1

MODERATE CERTAINTY in the evidence (but see 'What we don't know' below)
The practical impact of user feedback on PILs
Imagine a trial that needs to recruit 30 participants and initial recruitment is 30% of those approached. This means you'd need to approach 100 people to recruit 30 of them (see chart below).

Now imagine using a participant information leaflet developed using feedback. The chart below shows the impact of an absolute increase of 0% (95% CI = -2% to 2%)1. Recruitment is still 30%, which means our best estimate is that 100 people would still need to be approached to recruit 30 of them.

Where have brief participant information leaflets (PIL) been tested?
Intervention:
Comparison:
Scale:
Study 1: Cockayne 2017
Participants?
Patients eligible for the REFORM study (over 64 years, routine podiatry appointment in past 6 months) and offered an appointment at NHS podiatry clinics across 5 centres.
Trial intervention?
An orthosis.
Study location?
Community NHS clinics, UK.
What difference?
3.0% of those receiving the PIL with user feedback were recruited; 2.7% of those receiving the standard PIL were recruited.
Study 2: Chen 2011
Participants?
Participants were eligible for 3 host trials, but unclear what the trials were.
Trial intervention?
Unclear.
Study location?
Unclear but probably secondary, UK.
What difference?
6.1% of those receiving the PIL with user-feedback were recruited to a pre-randomisation phase; 5.6% of those receiving the standard PIL were recruited to the pre-randommisation phase.
What we still don’t know about PILs with user feedback
- The information we have is based on a two trials, one of which (Chen 2011) us actually recruitment to a pre-randomisation phase so has pulled down the GRADE rating to moderate because of indirectness. Ideally we need to test this intervention in more trials.
- Both trials were done in the UK; evaluations outside the UK would be welcome.
- Please get in touch (email info@trialforge.org) if you would like to do an evaluation because we can help with text for ethics etc.